CLINICAL STUDIES
The natural history of aortic valve disease after mitral valve surgery
Mordehay Vaturi, MD*,
Avital Porter, MD*,
Yehuda Adler, MD*,
Yaron Shapira, MD*,
Gideon Sahar, MD ,
Bernardo Vidne, MD and
Alex Sagie, MD*
* Dan Scheingarten Echocardiography Unit and Valvular Clinic, Cardiology Department, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv, Israel
Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv, Israel
Manuscript received October 31, 1998;
revised manuscript received January 11, 1999,
accepted February 8, 1999.
Reprint requests and correspondence: Dr. Alex Sagie, Dan Scheingarten Echocardiography Unit, Department of Cardiology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel
OBJECTIVES
The present study evaluates the long-term course of aortic valve disease and the need for aortic valve surgery in patients with rheumatic mitral valve disease who underwent mitral valve surgery.
BACKGROUND
Little is known about the natural history of aortic valve disease in patients undergoing mitral valve surgery for rheumatic mitral valve disease. In addition there is no firm policy regarding the appropriate treatment of mild aortic valve disease while replacing the mitral valve.
METHODS
One-hundred thirty-one patients (44 male, 87 female; mean age 61 ± 13 yr, range 35 to 89) were followed after mitral valve surgery for a mean period of 13 ± 7 years. All patients had rheumatic heart disease. Aortic valve function was assessed preoperatively by cardiac catheterization and during follow-up by transthoracic echocardiography.
RESULTS
At the time of mitral valve surgery, 59 patients (45%) had mild aortic valve disease: 7 (5%) aortic stenosis (AS), 58 (44%) aortic regurgitation (AR). At the end of follow-up, 96 patients (73%) had aortic valve disease: 33 AS (mild or moderate except in two cases) and 90 AR (mild or moderate except in one case). Among patients without aortic valve disease at the time of the mitral valve surgery, only three patients developed significant aortic valve disease after 25 years of follow-up procedures. Disease progression was noted in three of the seven patients with AS (2 to severe) and in six of the fifty eight with AR (1 to severe). Fifty two (90%) with mild AR remained stable after a mean follow-up period of 16 years. In only three patients (2%) the aortic valve disease progressed significantly after 9, 17 and 22 years. In only six patients of the entire cohort (5%), aortic valve replacement was needed after a mean period of 21 years (range 15 to 33). In four of them the primary indication for the second surgery was dysfunction of the prosthetic mitral valve.
CONCLUSIONS
Our findings indicate that, among patients with rheumatic heart disease, a considerable number of patients have mild aortic valve disease at the time of mitral valve surgery. Yet most do not progress to severe disease, and aortic valve replacement is rarely needed after a long follow-up period. Thus, prophylactic valve replacement is not indicated in these cases.
|
Abbreviations and Acronyms
| | AR | = aortic regurgitation | | AS | = aortic stenosis | | AV | = aortic valve | | CABG | = coronary artery bypass grafting | | Fc | = functional class | | LVEF | = left ventricular ejection fraction |
|
This article has been cited by other articles:
|
|
|
|
 
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper
CHAPTER 21 Valvular Heart Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
October 7, 2008;
118(15):
e523 - e661.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
September 23, 2008;
52(13):
e1 - e142.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
e1 - e148.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
598 - 675.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Choudhary, S. Talwar, and A. S. Kumar
Late outcome of mild or moderate aortic valve disease present at the time of mitral valve intervention
Ann. Thorac. Surg.,
November 1, 2003;
76
(5):
1774 - 1775.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-W. Ha, S.-H. Choi, B.-C. Chang, C. M. Nam, Y. Jang, N. Chung, W.-H. Shim, S.-Y. Cho, and S.-S. Kim
Is prophylactic aortic valve replacement indicated during mitral valve surgery for mild to moderate aortic valve disease?
Ann. Thorac. Surg.,
October 1, 2002;
74(4):
1115 - 1119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chauvaud, J.-F. Fuzellier, A. Berrebi, A. Deloche, J.-N. Fabiani, and A. Carpentier
Long-Term (29 Years) Results of Reconstructive Surgery in Rheumatic Mitral Valve Insufficiency
Circulation,
September 18, 2001;
104
(2009):
I-12 - I-15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Choudhary, S. Talwar, R. Juneja, and A. S. Kumar
Fate of mild aortic valve disease after mitral valve intervention
J. Thorac. Cardiovasc. Surg.,
September 1, 2001;
122(3):
583 - 586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Al Halees, B. Gometza, A. Al Sanei, and C. Duran
Repair of moderate aortic valve lesions associated with other pathology: an 11-year follow-up
Eur. J. Cardiothorac. Surg.,
August 1, 2001;
20(2):
247 - 251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Gillinov, E. H. Blackstone, J. White, M. Howard, R. Ahkrass, A. Marullo, and D. M. Cosgrove
Durability of combined aortic and mitral valve repair
Ann. Thorac. Surg.,
July 1, 2001;
72(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
